RecruitingPhase 3NCT06971731
A Study to Evaluate the Safety and Efficacy of JNT-517 in Participants With Phenylketonuria (PKU)
Studying Phenylketonuria
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Principal Investigator
- Otsuka Call Center
- Intervention
- JNT-517 Tablet(drug)
- Enrollment
- 120 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2027
Study locations (20)
- University of California Los Angeles (UCLA) School of Medicine, Los Angeles, California, United States
- University of Florida (UF) Health Shands Hospital, Gainesville, Florida, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- Oregon Health and Science University, Portland, Oregon, United States
- University of Pittsburgh Medical Center (UPMC) - Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
- University of Texas Southwestern, Dallas, Texas, United States
- University of Texas Health (UTHealth) Science Center at Houston, Houston, Texas, United States
- Utah Health - The University of Utah Hospital, Salt Lake City, Utah, United States
- Royal Adelaide Hospital, Adelaide, Australia
- Royal Melbourne Hospital, Parkville, Australia
- Mater Health - Mater Hospital Brisbane, South Brisbane, Australia
- Centre Hospitalier Régional Universitaire (CHRU) de Tours - Hôpital Bretonneau, Tours, France
- Nihon University Hospital, Chiyoda-ku, Japan
- Osaka Metropolitan University Hospital, Osaka, Japan
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06971731 on ClinicalTrials.govOther trials for Phenylketonuria
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE1NCT07255599Evaluation of BH4 Responsiveness in Our PKU PatientsSohag University
- RECRUITINGNANCT06941532GMP Powdered Substitutes in PKU and TYRNutricia UK Ltd
- ENROLLING BY INVITATIONNANCT06940193A Self-test Home-use Blood Phenylalanine Monitoring System Under the Brand Name Egoo Phe System Has Been Developed for Measurement of Phenylalanine (Phe) in Individuals Diagnosed With Phenylketonuria (PKU): The Study Purpose is to Evaluate Accuracy and UsabilityEgoo Health Aps
- ACTIVE NOT RECRUITINGPHASE4NCT06901323Effect of L-carnitine Supplementation on Phenylalanine and Brain-derived Neurotrophic Factor Levels in Infants and Children With PhenylketonuriaMansoura University
- RECRUITINGNANCT06969209Brain Aging in PhenylketonuriaInsel Gruppe AG, University Hospital Bern
- RECRUITINGPHASE1NCT06332807AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)NGGT INC.
- RECRUITINGNANCT06560736Development of Novel Psychological Assessment Tools and Anxiety Intervention for PhenylketonuriaUniversity of Missouri-Columbia
- RECRUITINGNANCT06718842Walking Program in Fatty Liver Children With PhenylketonuriaCairo University